Pamela Ann Connealy's most recent trade in Orchestra BioMed Holdings Inc was a trade of 15,000 Common Stock, par value $0.0001 per share ("Common Stock") done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Pamela Ann Connealy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 15,000 | 48,711 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Pamela Ann Connealy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 36,797 | 36,797 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Pamela Ann Connealy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 12,422 | 33,711 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |